ZA952243B - Recombinant viruses their preparation and their use in gene therapy - Google Patents

Recombinant viruses their preparation and their use in gene therapy

Info

Publication number
ZA952243B
ZA952243B ZA952243A ZA952243A ZA952243B ZA 952243 B ZA952243 B ZA 952243B ZA 952243 A ZA952243 A ZA 952243A ZA 952243 A ZA952243 A ZA 952243A ZA 952243 B ZA952243 B ZA 952243B
Authority
ZA
South Africa
Prior art keywords
preparation
gene therapy
recombinant viruses
viruses
recombinant
Prior art date
Application number
ZA952243A
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA952243B publication Critical patent/ZA952243B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA952243A 1994-03-18 1995-03-17 Recombinant viruses their preparation and their use in gene therapy ZA952243B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403192A FR2717497B1 (en) 1994-03-18 1994-03-18 Recombinant viruses, preparation and use in gene therapy.

Publications (1)

Publication Number Publication Date
ZA952243B true ZA952243B (en) 1996-01-09

Family

ID=9461191

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952243A ZA952243B (en) 1994-03-18 1995-03-17 Recombinant viruses their preparation and their use in gene therapy

Country Status (8)

Country Link
EP (1) EP0750674A1 (en)
JP (1) JPH09510356A (en)
AU (1) AU1896095A (en)
CA (1) CA2184408A1 (en)
FR (1) FR2717497B1 (en)
IL (1) IL112994A0 (en)
WO (1) WO1995025802A1 (en)
ZA (1) ZA952243B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270452A (en) * 1988-11-28 1993-12-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Pure glia maturation factor
FR2688514A1 (en) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
FR2704234B1 (en) * 1993-04-22 1995-07-21 Centre Nat Rech Scient RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY.

Also Published As

Publication number Publication date
EP0750674A1 (en) 1997-01-02
CA2184408A1 (en) 1995-09-28
FR2717497B1 (en) 1996-04-12
AU1896095A (en) 1995-10-09
WO1995025802A1 (en) 1995-09-28
JPH09510356A (en) 1997-10-21
IL112994A0 (en) 1995-06-29
FR2717497A1 (en) 1995-09-22

Similar Documents

Publication Publication Date Title
ZA949104B (en) Recombinant viruses and their use in gene therapy
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
ZA952563B (en) Recombinant viruses their preparation and their use in gene therapy
IL115584A0 (en) Viral vectors and their use in gene therapy
AU4032893A (en) Human papilloma virus genes and their use in gene therapy
ZA945012B (en) Viral vectors and their use in gene therapy
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
HU9503751D0 (en) Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
SG54275A1 (en) Dna coding for decarbamylase improved in thermostability and use thereof
ZA949103B (en) Recombinant viruses and their use in gene therapy
EP0752472A4 (en) Novel gene originating in corynebacterium and use thereof
ZA956849B (en) Use of a defective recombinant adenovirus in gene therapy
IL117466A0 (en) Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
IL112075A0 (en) Recombinant human thymopoietin proteins, their preparation and their medicinal use
ZA952242B (en) Recombinant viruses their preparation and their use in gene therapy
ZA964563B (en) Isoindole derivatives their preparation and their application in therapy
ZA952244B (en) Recombinant viruses their preparation and their use in gene therapy
IL128902A0 (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
FR2725213B1 (en) VIRAL VECTORS AND USE IN GENE THERAPY
IL113725A0 (en) Preparing recombinant aprotini and its variants
ZA952286B (en) Recombinant viruses their preparation and their use in gene therapy
ZA952243B (en) Recombinant viruses their preparation and their use in gene therapy